Important

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.

Product Documentation

Details, specifications, and documents

Description

GLOW 70 mg peptide blend

Buy GLOW peptide blend 70 mg for laboratory research. Each boxed 3 mL vial contains lyophilized powder with three labeled components: GHK-Cu 50 mg, TB-500 10 mg and BPC-157 10 mg.

  • GHK-Cu: 50 mg per vial
  • TB-500: 10 mg per vial
  • BPC-157: 10 mg per vial
  • Total blend: 70 mg per vial

The GHK-Cu component is the peptide-copper complex identified by CAS 89030-95-5. The TB-500 component is full-length, N-acetylated thymosin beta-4: a 43-amino-acid peptide identified by CAS 77591-33-4.

GLOW composition and product choice

GLOW contains three ingredients. The KLOW 80 mg blend includes the same labeled amounts plus 10 mg of KPV. The names are not interchangeable, so compare the component list rather than choosing by the total milligrams alone.

The 50 mg GHK-Cu amount describes the complete peptide-copper complex, including copper. It is not 50 mg of copper alone or copper-free GHK. A premixed vial also fixes the ingredient proportions. If a study needs a separate copper-peptide control, the GHK-Cu product is a different presentation to consider.

What the component studies show

Maquart and colleagues reported increased collagen synthesis in fibroblast cultures exposed to GHK-Cu, independently of changes in cell number. That result describes the copper-peptide complex in a cell model.

BPC-157 experiments examined migration in rat-derived tendon cells. TB-500 analytical research identified an acetylated seven-residue fragment in a different preparation. That study does not characterize this blend’s full-length TB-500 component.

The cited studies used individual materials and different experimental systems. They do not demonstrate synergy or predict the performance of this three-component mixture. Compare the complete formulation with appropriate component controls when interpreting results.

Certificate of analysis and product documentation

Open COA & Documents to review the available batch records. Match the lot and formulation, then check which components were identified and whether their amounts were measured separately. Purity, identity and component content answer different questions; one percentage cannot stand in for all three.

Use the supplied chemical forms for molecular calculations and the mixture’s documentation for handling and storage. The 3 mL figure describes vial capacity, not liquid supplied or a preparation volume.

Additional information

CAS No.

GHK-Cu: 89030-95-5, TB-500: 77591-33-4, BPC-157: 137525-51-0

Purity

≥99%

Synthesis Method

Solid-phase synthesis

Format

Lyophilized powder

Solubility

Water or validated laboratory buffer

Stability & Storage

Follow the product label and applicable laboratory storage procedure. A fixed shelf life is not specified here.

Applications

In-vitro assay research, compound characterization, analytical method development

Appearance

See lot-specific documentation

Regulatory/Compliance

Not for human consumption. For research use only.

Safety Information

See COA & Documents for available product records and handling guidance.

COA & Documents

Independent lot testing

GLOW 70mg Certificate of Analysis

This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.

Lot number
99723
Report number
IF-824-QSA-TR006-BTL26955-13
Date tested
July 15, 2026
Reported purity
99.7%
Labeled content
70 mg
DOWNLOADABLE RESOURCES

Product documents

Product information and laboratory resources. For lot-specific results, use the COA above.

PDF

Product & packaging information

Labeled amount, physical form and packaging for GLOW 70mg.

Revision 0.4 · 2026-10-05Download PDF
PDF

Laboratory handling guide

General guidance for applicable lyophilized research materials. Not a product-specific SDS.

Revision 1.0 · 2026-09-22Download PDF
General guides & resources

Need Assistance?

Questions about product documentation?

Contact our support team for help with product records, lot information, orders or certificate verification.

Contact Support